BORA - UiB

Bergen Open Research Archive

Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON® TB-Gold interferon-gamma assay

Bergen Open Research Archive

Show simple item record

dc.contributor.author Baba, Kamaldeen
dc.contributor.author Sørnes, Steinar
dc.contributor.author Hoosen, Anwar A.
dc.contributor.author Lekabe, Jacob M.
dc.contributor.author Mpe, Mathew J.
dc.contributor.author Langeland, Nina
dc.contributor.author Dyrhol-Riise, Anne M.
dc.date.accessioned 2008-06-04T06:07:09Z
dc.date.available 2008-06-04T06:07:09Z
dc.date.issued 2008-03-14
dc.identifier.citation BMC Infectious Diseases 2008 8(35) en
dc.identifier.issn 1471-2334
dc.identifier.uri http://dx.doi.org/10.1186/1471-2334-8-35
dc.identifier.uri http://hdl.handle.net/1956/2697
dc.description.abstract Background: Diagnosis of tuberculous (TB) pleuritis is difficult and better diagnostic tools are needed. New blood based interferon-gamma (IFN-γ) tests are promising, but sensitivity could be low in HIV positive patients. The IFN-γ tests have not yet been validated for use in pleural fluid, a compartment with higher level of immune activation than in blood. Methods: The QuantiFERON TB®-Gold (QFT-TB) test was analysed in blood and pleural fluid from 34 patients presenting with clinically suspected pleural TB. Clinical data, HIV status and CD4 cell counts were recorded. Adenosine deaminase activity (ADA) analysis and TB culture were performed on pleural fluid. Results: The patients were categorised as 'confirmed TB' (n = 12), 'probable TB' (n = 16) and 'non-TB' pleuritis (n = 6) based on TB culture results and clinical and biochemical criteria. The majority of the TB patients were HIV infected (82%). The QFT-TB in pleural fluid was positive in 27% and 56% of the 'confirmed TB' and 'probable TB' cases, respectively, whereas the corresponding sensitivities in blood were 58% and 83%. Indeterminate results in blood (25%) were caused by low phytohemagglutinin (PHA = positive control) IFN-γ responses, significantly lower in the TB patients as compared to the 'non-TB' cases (p = 0.02). Blood PHA responses correlated with CD4 cell count (r = 0.600, p = 0.028). In contrast, in pleural fluid indeterminate results (52%) were caused by high Nil (negative control) IFN-γ responses in both TB groups. Still, the Nil IFN-γ responses were lower than the TB antigen responses (p < 0.01), offering a conclusive test for half of the patients. We did not find any correlation between blood CD4 cell count and IFN-γ responses in pleural fluid. Conclusion: The QFT-TB test in blood could contribute to the diagnosis of TB pleuritis in the HIV positive population. Still, the number of inconclusive results is too high to recommend the commercial QFT-TB test for routine use in pleural fluid in a TB/HIV endemic resource-limited setting. en
dc.language.iso eng en
dc.publisher BioMed Central en
dc.rights Copyright 2008 Baba et al; licensee BioMed Central Ltd.
dc.title Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON® TB-Gold interferon-gamma assay en
dc.type Journal article en
dc.type Peer reviewed en


Files in this item

 

This item appears in the following Collection(s)

Show simple item record

Search BORA


Browse

My Account